Skip to main content

Stunning facts about diabetes history....



The ancient Egyptians first described diabetes around 1500 BC.  It was described as a condition in which a person urinated excessively and lost weight.
The urine of diabetics was noted to be copious and sweet.  The Greek physician Aretaeus (80-138 C.E.) noted that the syndrome manifested as polyuria, and used the term, διαβήτης (diabetes), which means “a siphon, a passer through.”
In 1675, the English physician Thomas Willis added “mellitus” to the designation when he noticed that the urine of diabetics had a sweet odor.  Mellitus comes from the Latin root for “honey.”
Matthew Dobson documented elevated glucose levels in the urine of diabetics in 1776.
In 1889, Joseph von Mering and Oskar Minkowski found that removing the pancreas from dogs resulted in fatal diabetes.  This provided the first clue that the pancreas plays a key role in regulating glucose concentrations.
In 1910, Edward Albert Sharpey-Schafer hypothesized that diabetes was due to the deficiency of a chemical excreted by the pancreas.  He named this chemical “insulin”, from the Latin word insula, meaning island in reference to the pancreatic islet cells of Langerhans.
In 1921, Frederick Banting and Charles Best discovered insulin.  The researchers obtained extract from pancreatic islet cells of healthy dogs and administered it to diabetic dogs.  In doing so, they were able to reverse the diabetes.
Fifteen years after the discovery of insulin, in 1936, Harold Himsworth proposed the idea that many patients with diabetes may have insulin resistance rather than insulin deficiency.
From 1923 to 2012, only ten scientists have received the Nobel Prize for diabetes research.
The prevalence of diabetes has increased worldwide.  In the U.S. alone, the number of diabetes cases has increased during the time period of 1980 to 2010.  In 1980, there were 5.6 million people in the U.S. with diabetes.  In to 2010, there were 20.9 million people in the U.S. with diabetes.  (This represents 2.5% and 6.9% of the population, respectively.)  At this rate, 1 in 3 U.S. adults could have diabetes by 2050.

Comments

Popular posts from this blog

The 100 essentials in icu and anesthesia

The most visual experience in anesthesia and critical care education  The 100 essentials of anesthesia and critical care  COMING VERY SOON  stay tuned 

Driving Pressure in ARDS: A new concept!

Driving Pressure and Survival in the Acute Respiratory Distress Syndrome Marcelo B.P. Amato, M.D., Maureen O. Meade, M.D., Arthur S. Slutsky, M.D., Laurent Brochard, M.D., Eduardo L.V. Costa, M.D., David A. Schoenfeld, Ph.D., Thomas E. Stewart, M.D., Matthias Briel, M.D., Daniel Talmor, M.D., M.P.H., Alain Mercat, M.D., Jean-Christophe M. Richard, M.D., Carlos R.R. Carvalho, M.D., and Roy G. Brower, M.D. N Engl J Med 2015; 372:747-755 February 19, 2015 DOI: 10.1056/NEJMsa1410639 BACKGROUND Mechanical-ventilation strategies that use lower end-inspiratory (plateau) airway pressures, lower tidal volumes (V T ), and higher positive end-expiratory pressures (PEEPs) can improve survival in patients with the acute respiratory distress syndrome (ARDS), but the relative importance of each of these components is uncertain. Because respiratory-system compliance (C RS ) is strongly related to the volume of aerated remaining functional lung during disease (termed functional lung size)...